Bio-Techne Corporation
TECHHealthcare|Biotechnology|US
$72.78
+0.12 (+0.17%)
DCF Value
$23.03
Tangible Book / Share
$5.78
Graham Number
$18.46
Cash / Share
$2.23
Ownership Breakdown
99.4%
Float
157.1M
Shares Outstanding
156.2M
Float Shares
Major Holders (5)
Combined: 18.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | Investment adviser | 7.38% | 11,559,571 | Apr 29, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 7.00% | 11,011,556 | Jul 16, 2025 | 13D/G |
| T. Rowe Price Associates, Inc. | Investment adviser | 2.20% | 3,350,818 | Nov 14, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 0.70% | 1,088,114 | Nov 5, 2026 | 13D/G |
| FMR LLC | Holding company | 0.70% | 1,088,114 | Nov 5, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 783,383 acquired · 1,081,400 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kelderman Kim | director, officer: Chief Executive Officer | Nov 1, 2026 | TAX W/H | 2,385 | $72.66 | $173.3K | Form 4 |
| Hippel James | CFO | Nov 1, 2026 | OPTION EX. | 11,545 | — | — | Form 4 |
| Hippel James | CFO | Nov 1, 2026 | TAX W/H | 5,096 | $72.66 | $370.3K | Form 4 |
| Hippel James | CFO | Nov 1, 2026 | OPTION EX. | 11,545 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 9,980 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | TAX W/H | 4,423 | $72.40 | $320.2K | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 1,067 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 4,903 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 4,010 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | DISPOSED | 34,443 | $84.61 | $2.9M | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | DISPOSED | 12,798 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 6,547 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | TAX W/H | 2,019 | $72.40 | $146.2K | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | DISPOSED | 698 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 3,226 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 2,623 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | DISPOSED | 22,545 | $84.61 | $1.9M | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 8,376 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 21,736 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | TAX W/H | 10,955 | $72.40 | $793.1K | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 11,785 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 725 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 8,543 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 683 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 23,949 | $68.54 | $1.6M | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 22,044 | $84.61 | $1.9M | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 8,698 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 4,420 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | TAX W/H | 1,366 | $72.40 | $98.9K | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 2,332 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 370 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 1,669 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | DISPOSED | 11,929 | $84.61 | $1.0M | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 49 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | DISPOSED | 4,432 | — | — | Form 4 |
| Vessey Rupert | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| Seth Alpna | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| Klimovsky Judith V. | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| Herr Amy E. | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| KEEGAN JOSEPH D | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| HIGGINS JOHN L | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| Bushman Julie L | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| BAUMGARTNER ROBERT V | director | Oct 29, 2026 | AWARD | 2,750 | — | — | Form 4 |
| HIGGINS JOHN L | director | Sep 28, 2026 | OPTION EX. | 15,940 | — | — | Form 4 |
| HIGGINS JOHN L | director | Sep 28, 2026 | TAX W/H | 5,562 | $72.51 | $403.3K | Form 4 |
| HIGGINS JOHN L | director | Sep 28, 2026 | OPTION EX. | 15,940 | $25.30 | $403.3K | Form 4 |
| BAUMGARTNER ROBERT V | director | Sep 22, 2026 | OPTION EX. | 15,940 | — | — | Form 4 |
| BAUMGARTNER ROBERT V | director | Sep 22, 2026 | TAX W/H | 5,559 | $72.55 | $403.3K | Form 4 |
| BAUMGARTNER ROBERT V | director | Sep 22, 2026 | OPTION EX. | 15,940 | $25.30 | $403.3K | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 17, 2026 | AWARD | 18,432 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 17, 2026 | AWARD | 11,344 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 17, 2026 | AWARD | 93,582 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 17, 2026 | AWARD | 57,590 | — | — | Form 4 |
| Hippel James | CFO | Aug 17, 2026 | AWARD | 36,459 | — | — | Form 4 |
| Hippel James | CFO | Aug 17, 2026 | AWARD | 22,438 | — | — | Form 4 |
| Herr Amy E. | director | Aug 17, 2026 | AWARD | 1,381 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 17, 2026 | AWARD | 23,985 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 17, 2026 | AWARD | 14,762 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 17, 2026 | AWARD | 14,140 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 17, 2026 | AWARD | 8,702 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 21,470 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | TAX W/H | 10,821 | $72.40 | $783.4K | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 11,785 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 588 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 8,543 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | OPTION EX. | 554 | — | — | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 24,324 | $68.54 | $1.7M | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 22,389 | $84.61 | $1.9M | Form 4 |
| Kelderman Kim | director, officer: Chief Executive Officer | Aug 15, 2026 | DISPOSED | 8,835 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 9,779 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | TAX W/H | 4,310 | $72.40 | $312.0K | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 866 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 4,903 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | OPTION EX. | 4,010 | — | — | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | DISPOSED | 34,982 | $84.61 | $3.0M | Form 4 |
| Hippel James | CFO | Aug 15, 2026 | DISPOSED | 12,999 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 6,416 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | TAX W/H | 1,976 | $72.40 | $143.1K | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 567 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 3,226 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | OPTION EX. | 2,623 | — | — | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | DISPOSED | 22,898 | $84.61 | $1.9M | Form 4 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | DISPOSED | 8,507 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 4,350 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | TAX W/H | 1,343 | $72.40 | $97.2K | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 2,332 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 300 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 1,669 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | DISPOSED | 12,117 | $84.61 | $1.0M | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | OPTION EX. | 49 | — | — | Form 4 |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | DISPOSED | 4,502 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | OPTION EX. | 5,423 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | TAX W/H | 1,947 | $72.40 | $141.0K | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | OPTION EX. | 2,176 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | OPTION EX. | 1,868 | — | — | Form 4 |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | OPTION EX. | 1,379 | — | — | Form 4 |
| Herr Amy E. | director | Aug 15, 2026 | OPTION EX. | 589 | — | — | Form 4 |
| Herr Amy E. | director | Aug 15, 2026 | OPTION EX. | 311 | — | — | Form 4 |
| Herr Amy E. | director | Aug 15, 2026 | TAX W/H | 213 | $72.40 | $15.4K | Form 4 |
| Herr Amy E. | director | Aug 15, 2026 | OPTION EX. | 160 | — | — | Form 4 |
Congress & Senate Trades (33)
April McClain DelaneyHouse · MD06Apr 8, 2026
April McClain DelaneyHouse · MD06Mar 26, 2026
April McClain DelaneyHouse · MD06Feb 24, 2026
April McClain DelaneyHouse · MD06Jan 28, 2026
April McClain DelaneyHouse · MD06Dec 5, 2025
April McClain DelaneyHouse · MD06Dec 2, 2025
April McClain DelaneyHouse · MD06Oct 22, 2025
April McClain DelaneyHouse · MD06Aug 1, 2025
April McClain DelaneyHouse · MD06May 26, 2025
April McClain DelaneyHouse · MD06Apr 29, 2025
April McClain DelaneyHouse · MD06Apr 9, 2025
Robert P. BresnahanHouse · PA08Apr 8, 2025
Julie JohnsonHouse · TX32Apr 1, 2025
Robert P. BresnahanHouse · PA08Feb 25, 2025
Ro KhannaHouse · CA17Nov 3, 2023
Ro KhannaHouse · CA17Oct 2, 2023
Ro KhannaHouse · CA17Jun 26, 2023
Ro KhannaHouse · CA17May 23, 2023
Ro KhannaHouse · CA17Apr 10, 2023
Ro KhannaHouse · CA17Mar 14, 2023
Ro KhannaHouse · CA17Feb 10, 2023
Ro KhannaHouse · CA17Nov 3, 2022
Ro KhannaHouse · CA17May 23, 2022
Ro KhannaHouse · CA17May 10, 2022
Ro KhannaHouse · CA17May 5, 2022
Ro KhannaHouse · CA17Apr 11, 2022
Ro KhannaHouse · CA17Feb 17, 2022
Ro KhannaHouse · CA17Jan 21, 2022
Ro KhannaHouse · CA17Jan 20, 2022
Ro KhannaHouse · CA17Jan 11, 2022
Greg GianforteHouse · MT00Oct 13, 2020
Greg GianforteHouse · MT00Jan 24, 2019
Thomas Roland TillisSenate · NCFeb 13, 2015